Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

SHA:603392 Revenue

Beijing Wantai Biological Pharmacy Enterprise had revenue of 400.63M CNY in the quarter ending March 31, 2025, a decrease of -46.76%. This brings the company's revenue in the last twelve months to 1.89B, down -43.92% year-over-year. In the year 2024, Beijing Wantai Biological Pharmacy Enterprise had annual revenue of 2.25B, down -59.25%.

• Revenue (ttm): 1.89B
• Revenue Growth: -43.92%
• P/S Ratio: 40.36
• Revenue / Employee: 499.61K
• Employees: 3,790
• Market Cap: 76.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.25B	-3.27B	-59.25%
Dec 31, 2023	5.51B	-5.67B	-50.73%
Dec 31, 2022	11.19B	5.43B	94.51%
Dec 31, 2021	5.75B	3.40B	144.25%
Dec 31, 2020	2.35B	1.17B	98.88%